explore -WSS

explore

author：knowledge 2025-10-01 23:57:24 - browse：61315

Eric Lander White House science office — Eric Lander resigned as President Biden’s science adviser, after a White House investigation found “credible evidence” that he had violated workplace conduct rules. Photo illustration: Alex Hogan/STAT; Source: Getty

WASHINGTON — An early sign that trouble was afoot in the White House science office came last November, when roughly a dozen of Eric Lander’s staff formed a “culture committee” aimed at improving morale.

The group’s first action, five aides told STAT, was to create a “word cloud” depicting the adjectives they most often used to describe the work environment at the White House Office of Science and Technology Policy. Of the dozens of words submitted, three in particular stood out: “hostile,” “siloed,” and “aggressive.”

Three months later, Lander resigned as President Biden’s science adviser, after Politico reported a White House investigation that found “credible evidence” that he had violated workplace conduct rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Snackable artificial intelligence, expert AI, and the pharma industry

WSS

Snackable artificial intelligence, expert AI, and the pharma industry

Ethical issues complicate the benefits of medical crowdfunding

Illumina names Agilent executive as new CEO

Criminal prosecution for violating HIPAA: an emerging threat

How to fix cancer clinical trials' diversity problem

Why Novartis is changing the name of its research labs

focus

explore

focus

Cancer drug shortages should be causing more outrage

Illumina names Agilent executive as new CEO

State Dept. review finds Biden bears some blame for Afghanistan failures

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Walensky prepares to leave CDC — and Congress — behind

Anxious about a speech? A startup wants you to pop a minty cardiac drug

BioMarin wins approval for gene therapy to treat hemophilia A

What drug price negotiations mean for Medicare Part D

ChatGPT in medicine: STAT answers readers' burning questions

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

Weighted lottery helped low

NIH nominee Bertagnolli will get October confirmation hearing

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Helping hospitals and community health centers plan for resilience

Case highlights the risks of experimental stem cell therapy

NIH nominee Bertagnolli will get October confirmation hearing

knowledge

hotspot

hotspot

hotspot